Literature DB >> 19345564

Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005.

Marianna Alacqua1, Gianluca Trifirò, Edoardo Spina, Salvatore Moretti, Daniele Ugo Tari, P Bramanti, Achille P Caputi, Vincenzo Arcoraci.   

Abstract

AIM: To analyse the prescribing pattern of newer and older antiepileptic drugs (AEDs) during the years 2003-2005.
METHODS: From the Caserta-1 Local Health Service database, 93 general practitioners (GPs) were recruited. Among 127,389 individuals aged > or =15 years registered in the lists of these GPs, we selected patients who received at least one AED prescription during the study period. Use of newer and older AEDs was calculated as 1-year prevalence and incidence as well as defined daily dose (DDD) per 1000 inhabitants/day. Sub-analyses by gender, age and indication of use were performed.
RESULTS: Overall, prevalence and incidence of use remained stable for older AEDs, while it strongly increased for newer AEDs. In particular, 25% increase of incident treatments with newer AED have been reported from 2004 to 2005. The total volume of AED use remained stable during the study years, despite the proportion of newer AEDs slightly increased (from 24.6% in 2003 to 30.1% in 2005). The main indication of use was epileptic disorders for older AEDs (56% of users), and neuropathic pain for newer AEDs (69%).
CONCLUSIONS: Prevalence and incidence of use of newer AED strongly increased during the years 2003-2005 in a general practice of Southern Italy. Significant differences are shown in the prescribing pattern of newer and older medications: older AEDs are mainly used in the treatment of epileptic disorders, while newer compounds are preferred for conditions other than epilepsy, in particular neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19345564     DOI: 10.1016/j.eplepsyres.2009.03.002

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  14 in total

1.  Antiepileptic drug use in community-dwelling and institutionalized elderly: a nationwide study of over 1,300,000 older people.

Authors:  Kristina Johnell; Johan Fastbom
Journal:  Eur J Clin Pharmacol       Date:  2011-04-28       Impact factor: 2.953

Review 2.  Risk of falls associated with antiepileptic drug use in ambulatory elderly populations: A systematic review.

Authors:  Mira Maximos; Feng Chang; Tejal Patel
Journal:  Can Pharm J (Ott)       Date:  2017-03-01

3.  Trends in Antiepileptic Drug Prescriptions for Childhood Epilepsy at a Tertiary Children's Hospital in Korea, 2001-2012.

Authors:  Yoon Sook Cho; Young-Mi Ah; Ae Hee Jung; Ki Joong Kim; Ju-Yeun Lee
Journal:  Paediatr Drugs       Date:  2015-12       Impact factor: 3.022

4.  Antiepileptic use for epilepsy and nonepilepsy disorders: A population-based study (1998-2013).

Authors:  Christine Leong; Muhammad M Mamdani; Tara Gomes; David N Juurlink; Erin M Macdonald; Marina Yogendran
Journal:  Neurology       Date:  2016-02-05       Impact factor: 9.910

5.  Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011.

Authors:  Domenico Italiano; Annalisa Capuano; Angela Alibrandi; Rosarita Ferrara; Angelo Cannata; Gianluca Trifirò; Janet Sultana; Carmen Ferrajolo; Michele Tari; Daniele Ugo Tari; Margherita Perrotta; Claudia Pagliaro; Concita Rafaniello; Edoardo Spina; Vincenzo Arcoraci
Journal:  Br J Clin Pharmacol       Date:  2015-06       Impact factor: 4.335

Review 6.  A review of the effect of anticonvulsant medications on bone mineral density and fracture risk.

Authors:  Richard H Lee; Kenneth W Lyles; Cathleen Colón-Emeric
Journal:  Am J Geriatr Pharmacother       Date:  2010-02

7.  Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany--a nationwide population-based study in children and adults.

Authors:  Hajo M Hamer; Richard Dodel; Adam Strzelczyk; Monika Balzer-Geldsetzer; Jens-Peter Reese; Oliver Schöffski; Wolfgang Graf; Stefan Schwab; Susanne Knake; Wolfgang H Oertel; Felix Rosenow; Karel Kostev
Journal:  J Neurol       Date:  2012-04-28       Impact factor: 4.849

8.  Trends in the use of antiepileptic drugs among pregnant women in the US, 2001-2007: a medication exposure in pregnancy risk evaluation program study.

Authors:  William V Bobo; Robert L Davis; Sengwee Toh; De-Kun Li; Susan E Andrade; T Craig Cheetham; Pamala Pawloski; Sascha Dublin; Simone Pinheiro; Tarek Hammad; Pamela E Scott; Richard A Epstein; Patrick G Arbogast; James A Morrow; Judith A Dudley; Jean M Lawrence; Lyndsay A Avalos; William O Cooper
Journal:  Paediatr Perinat Epidemiol       Date:  2012-11       Impact factor: 3.980

9.  Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study.

Authors:  Ylenia Ingrasciotta; Janet Sultana; Francesco Giorgianni; Andrea Fontana; Antonio Santangelo; Daniele Ugo Tari; Domenico Santoro; Vincenzo Arcoraci; Margherita Perrotta; Luisa Ibanez; Gianluca Trifirò
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

10.  The role of phenytoin in the treatment of localization related epilepsy: an international internet-based survey of neurologists and epileptologists.

Authors:  Rohit R Das; David A Griesemer; Sanjeev V Kothare
Journal:  ISRN Neurol       Date:  2013-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.